Phenylboronic Acid Functionalized Resveratrol-based Nanomedicines with Enhanced Targeting for Synergistic Chemo-Photothermal Breast Cancer Therapy

Key Points

• The aim is to develop nanomedicines that combine photothermal therapy and chemotherapy to improve breast cancer treatment effectiveness.
• Development of phenylboronic acid functionalized resveratrol-based nanomedicines.
• Assessment of targeting efficiency in cancer cells.
• Evaluation of combined photothermal and chemotherapy effects.
• Enhanced targeting efficiency of the nanomedicines in tumor cells.
• Synergistic effects observed with combined photothermal therapy and chemotherapy.
• Improvement in cancer cell death rates compared to traditional therapies.